+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphoma"

From
From
From
From
Hematology Diagnostics Market Analysis and Industry Forecast - Product Thumbnail Image

Hematology Diagnostics Market Analysis and Industry Forecast

  • Report
  • April 2026
  • 128 Pages
  • Global
From
From
From
From
From
2022 ASCO Weekend Update - Product Thumbnail Image

2022 ASCO Weekend Update

  • Newsletter
  • November 2026
  • 88 Pages
  • Global
Global Oncology Market Strategic Research Report 2026-2031 - Product Thumbnail Image

Global Oncology Market Strategic Research Report 2026-2031

  • Report
  • August 2026
  • 328 Pages
  • Global
From
Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • February 2026
  • 229 Pages
  • Global
From
From
From
From
Loading Indicator

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments. Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more